Cocaine Selectively Raised Brain Dynorphin Through Dopamine Signaling

Subchronic cocaine selectively increased striatonigral dynorphin through a dopaminergic mechanism requiring both D1 and D2 receptors — enkephalin and substance P were unchanged.

Sivam, S P·The Journal of pharmacology and experimental therapeutics·1989·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00136Animal StudyPreliminary Evidence1989RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Subchronic cocaine selectively increased striatonigral dynorphin through a dopaminergic mechanism requiring both D1 and D2 receptors. Enkephalin and substance P were unaffected.

Key Numbers

How They Did This

Rats received cocaine (20 mg/kg/day for 4 days). Brain peptide levels were measured by radioimmunoassay. Dopamine involvement was confirmed using 6-OHDA lesions and D1/D2 antagonists.

Why This Research Matters

Dynorphin increases may represent the brain's attempt to counteract cocaine's rewarding effects. This compensatory response could contribute to withdrawal symptoms and tolerance.

The Bigger Picture

Cocaine selectively rewiring the dynorphin system may be a compensatory response — dynorphin generally produces dysphoria (unpleasant feelings), which could serve as a natural brake on cocaine reward.

What This Study Doesn't Tell Us

Animal study using a relatively short cocaine regimen. Human cocaine use patterns are more variable. The functional consequences of elevated dynorphin were not directly tested.

Questions This Raises

  • ?Does dynorphin increase contribute to cocaine crash and dysphoria?
  • ?Could dynorphin-targeting drugs treat cocaine addiction?

Trust & Context

Key Stat:
Selective dynorphin increase Cocaine raised only dynorphin via D1+D2 dopamine — other peptides unchanged
Evidence Grade:
Preliminary animal study with good controls (6-OHDA lesions, selective antagonists).
Study Age:
Published in 1989 — established the cocaine-dynorphin connection in addiction neuroscience.
Original Title:
Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Published In:
The Journal of pharmacology and experimental therapeutics, 250(3), 818-24 (1989)
Authors:
Sivam, S P(2)
Database ID:
RPEP-00136

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Why does cocaine increase dynorphin?

Cocaine floods the brain with dopamine, which activates both D1 and D2 receptors in the striatum. These receptors trigger dynorphin gene expression as a compensatory response.

Is dynorphin increase good or bad?

Dynorphin produces dysphoria (negative mood), which may serve as a natural brake on cocaine use. However, this dynorphin increase may also drive the negative emotional state during cocaine withdrawal.

Read More on RethinkPeptides

Cite This Study

RPEP-00136·https://rethinkpeptides.com/research/RPEP-00136

APA

Sivam, S P. (1989). Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.. The Journal of pharmacology and experimental therapeutics, 250(3), 818-24.

MLA

Sivam, S P. "Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.." The Journal of pharmacology and experimental therapeutics, 1989.

RethinkPeptides

RethinkPeptides Research Database. "Cocaine selectively increases striatonigral dynorphin levels..." RPEP-00136. Retrieved from https://rethinkpeptides.com/research/sivam-1989-cocaine-selectively-increases-striatonigral

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.